Navigation Links
Temporary Production Interruption at Allston Landing Manufacturing Facility Has No Impact on Aldurazyme
Date:6/16/2009

on BioMarin's website is not incorporated by reference into this press release.

Forward-Looking Statement

This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the development of its product candidate PEG-PAL, the timing, design, conduct and expectations related to the PEG-PAL clinical trials, and expectations regarding filings with regulatory agencies. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: the results of current and planned clinical trials related to PEG-PAL; the content and timing of decisions by the U.S. Food and Drug Administration and other regulatory agencies, particularly with respect to PEG-PAL, and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise.

BioMarin(R), Naglazyme(R) and Kuvan(R) are a registered trademarks of BioMarin Pharmaceutical Inc.

Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC.

    Contact:

    Investors:                         Media:
    Eugenia Shen                       Susan Berg
    BioMarin Pharmaceutical Inc.       BioMarin Pharmaceutical Inc.
    (415) 506-6570                     (415) 506-6594


'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. United Animal Nations Offers Financial Assistance Grants of up to $500 to Help Southern California Fire Victims Obtain Vet Care, Temporary Boarding for Pets
2. UniCare Announces Temporary Pharmacy Guidelines for Customers Affected by the California Wildfires
3. Homeless cells find temporary lodging -- and their demise
4. Aviva Belsky Promoted to Publisher of Contemporary Surgery
5. Some types of temporary neurological problems associated with increased risk for stroke, dementia
6. Temporary Amnesia, Confusion Raise Stroke, Dementia Risk
7. WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
8. Statement by SEIU International President Andy Stern Regarding CNA Temporary Restraining Order
9. Temporary dentures improve patients smiles and overall health
10. Drug Effective for Temporary Sleep Disruptions
11. Unitemp Announces Unprecedented Temporary Staffing Services Guarantee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... become an increasing concern to health officials both in ... Department of Health and Mental Hygiene, the number of ... the number of such deaths in 2000. Much of ... in nonmedical prescription opioid (PO) use among teens and ... youth who transitioned from POs to heroin. , ...
(Date:9/2/2014)... Two Kansas State University biochemists have discovered a family ... Staphylococcus aureus , a pathogenic bacterium that can ... , Brian Geisbrecht, professor of biochemistry and molecular biophysics, ... S. aureus , which is the cause of increasing ... journal Proceedings of the National Academy of Sciences ...
(Date:9/2/2014)... that a mother,s eating habits prior to pregnancy, during ... her offspring and their propensity for developing weight problems, ... this phenomenon were unclear. According to new research published ... FASEB Journal F , scientists using an animal model ... an offspring,s risk of future obesity. This link hinges ...
(Date:9/2/2014)... Many people believe that marijuana is not addictive, but ... people are able to obtain and consume cannabis legally ... are less likely to perceive it as addictive or ... General Hospital,s Center for Addiction Medicine, said in a ... use can have significant consequences, and we know that ...
(Date:9/2/2014)... HMP Communications Holdings , LLC, a leader ... the acquisition of Nutrition411.com , a vibrant news ... who integrate diet and nutrition into patient consultations. , ... , Late-breaking news related to nutrition and disease ... oncology, renal disease, wound care, and pediatrics , ...
Breaking Medicine News(10 mins):Health News:NYC teens and young adults who abuse prescription at high risk for overdose 2Health News:NYC teens and young adults who abuse prescription at high risk for overdose 3Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2
... converts to Masimo SET pulse oximetry and leverages ... ... capabilities, IRVINE, Calif., Feb. 13 Masimo, the inventor,of Pulse ... of UCSF Medical Center,s,system-wide implementation of Masimo SET pulse oximetry and ...
... SEATTLE, Feb. 13 An intriguing new offering ... Climb to Fight,Breast Cancer(R) benefiting Fred Hutchinson Cancer Research ... international slate of peaks to,include two expeditions to central ... (17,343 feet). Both trips will be led by,professional guides ...
... Underwriters, Inc. (Darwin) (NYSE: DR ) ... Specialty Product Network Insurance,Services, Inc. (ASPN)., ... the announced arrangement, ASPN,s nationwide team of ... intended to spread the,word about Darwin,s unique ...
... been able to eradicate the virus from infected individuals who ... HIV in hideouts known as viral reservoirs. One important reservoir ... due to the large number of HIV target cells that ... largely contained in lymph nodes and patches of lymphocytes that ...
... TOWN, W.V., Feb. 13 ReBuilder Medical,Technologies, ... of the art,electronic devices for diabetic peripheral ... up 89% over last year, details,are available ... ., (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ), ...
... results need to be replicated in larger study, experts ... drug originally designed to combat cancer that is now ... arthritis and lupus might also work against a common ... in the Feb. 14 issue of the New ...
Cached Medicine News:Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 2Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 3Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 4Health News:The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology 5Health News:Climb to Fight Breast Cancer Offers Peaks for Every Skill Level 2Health News:Darwin Enters into Marketing Partnership with Agency Specialty Product Network 2Health News:HIV persists in the gut despite long-term HIV therapy 2Health News:ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006 2Health News:Cancer Drug Works Against MS in Early Trial 2Health News:Cancer Drug Works Against MS in Early Trial 3
(Date:9/2/2014)... 2, 2014  EMD Serono, Inc., a subsidiary of ... today that Drew Young has joined the ... this capacity, he will be responsible for leading the ... including future products.   Bringing more than 20 ... sales efforts at pharmaceutical and biotech companies, Mr. Young ...
(Date:9/2/2014)... 2014  Cyberonics, Inc. (NASDAQ: CYBX ... study.  Results of the study presented by a ... cardiology congress and concurrently published by the ... Therapy (ART) in patients with moderate to severe ... safe, improves the heart,s ability to pump blood, ...
(Date:9/2/2014)... , Sept. 2, 2014 ResMed (NYSE: ... 150 devices in the United States ... portable, lightweight, and user-friendly life support ventilators. ... mobility and ease of use for patients suffering from ... adult and childhood respiratory disorders. The U.S. launch comes ...
Breaking Medicine Technology:EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 2EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 3EMD Serono Appoints Drew Young to Senior Vice President, Neurology and Immunology 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 2ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 3ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 4ANTHEM-HF Shows Autonomic Regulation Therapy Is Safe And Improves Heart Function In Patients With Chronic Heart Failure 5ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3
... Formation in ... Animals, Hearts, SUNRISE, ... of myoblasts modified to express,stromal derived factor-1(alpha) protein (SDF-1) into the ... were recently,presented at two scientific meetings -- the International Society for,Magnetic ...
... Enrollment Program Speeds Oncology Patient Accrual, ... Research Management,Organization (RMO), has contracted with five ... management services for their,clinical trials using the ... the following disease indications: follicular Non-Hodgkin,s,Lymphoma, Metastatic ...
Cached Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2
... DXC-990 camera is a 3 chip 1/2 inch color ... and a high s/n ratio. It offers picture contrast ... and knee control. The user can choose automatic exposure ... The Sony DXC-990 camera is a bayonet mount and ...
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
... image management. Mediscan is an advanced ... derived from extensive experience with clinicians. ... organize, and distribute high quality images, ... effort. Can be connected to flexible ...
For continuous intracranial monitoring of pressure, oxygen and temperature of the brain...
Medicine Products: